Global Anti-Infective Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publisher Name :
Date: 18-Jan-2023
No. of pages: 117

According to our (Global Info Research) latest study, the global Anti-Infective Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Anti-Infective Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Anti-Infective Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Anti-Infective Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Anti-Infective Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Anti-Infective Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Anti-Infective Vaccines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Anti-Infective Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC and Novartis Vaccines, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Anti-Infective Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

- Inactivated Vaccines

- Conjugate Vaccines

- Live/attenuated Vaccines

Market segment by Application

- Bacterial Diseases

- Viral Diseases

Major players covered

- Emergent BioDefense Operations Lansing Inc.

- Sanofi Pasteur

- Merck & Co.

- MedImmune LLC

- Novartis Vaccines

- Diagnostics Ltd.

- Intercell Biomedical

- MassBiologics

- Barr Labs, Inc.

- Organon Teknika Co.

- GlaxoSmithKline Biologicals

- CSL Ltd.

- ID Biomedical Co.

- Protein Sciences Co.

- Wyeth Pharmaceuticals, Inc.

- Berna Biotech

Market segment by region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Anti-Infective Vaccines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Anti-Infective Vaccines, with price, sales, revenue and global market share of Anti-Infective Vaccines from 2018 to 2023.

Chapter 3, the Anti-Infective Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Anti-Infective Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-Infective Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-Infective Vaccines.

Chapter 14 and 15, to describe Anti-Infective Vaccines sales channel, distributors, customers, research findings and conclusion.

Global Anti-Infective Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Anti-Infective Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-Infective Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Inactivated Vaccines
1.3.3 Conjugate Vaccines
1.3.4 Live/attenuated Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-Infective Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Bacterial Diseases
1.4.3 Viral Diseases
1.5 Global Anti-Infective Vaccines Market Size & Forecast
1.5.1 Global Anti-Infective Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-Infective Vaccines Sales Quantity (2018-2029)
1.5.3 Global Anti-Infective Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Emergent BioDefense Operations Lansing Inc.
2.1.1 Emergent BioDefense Operations Lansing Inc. Details
2.1.2 Emergent BioDefense Operations Lansing Inc. Major Business
2.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product and Services
2.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Anti-Infective Vaccines Product and Services
2.2.4 Sanofi Pasteur Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Merck & Co.
2.3.1 Merck & Co. Details
2.3.2 Merck & Co. Major Business
2.3.3 Merck & Co. Anti-Infective Vaccines Product and Services
2.3.4 Merck & Co. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck & Co. Recent Developments/Updates
2.4 MedImmune LLC
2.4.1 MedImmune LLC Details
2.4.2 MedImmune LLC Major Business
2.4.3 MedImmune LLC Anti-Infective Vaccines Product and Services
2.4.4 MedImmune LLC Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MedImmune LLC Recent Developments/Updates
2.5 Novartis Vaccines
2.5.1 Novartis Vaccines Details
2.5.2 Novartis Vaccines Major Business
2.5.3 Novartis Vaccines Anti-Infective Vaccines Product and Services
2.5.4 Novartis Vaccines Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Vaccines Recent Developments/Updates
2.6 Diagnostics Ltd.
2.6.1 Diagnostics Ltd. Details
2.6.2 Diagnostics Ltd. Major Business
2.6.3 Diagnostics Ltd. Anti-Infective Vaccines Product and Services
2.6.4 Diagnostics Ltd. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Diagnostics Ltd. Recent Developments/Updates
2.7 Intercell Biomedical
2.7.1 Intercell Biomedical Details
2.7.2 Intercell Biomedical Major Business
2.7.3 Intercell Biomedical Anti-Infective Vaccines Product and Services
2.7.4 Intercell Biomedical Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Intercell Biomedical Recent Developments/Updates
2.8 MassBiologics
2.8.1 MassBiologics Details
2.8.2 MassBiologics Major Business
2.8.3 MassBiologics Anti-Infective Vaccines Product and Services
2.8.4 MassBiologics Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 MassBiologics Recent Developments/Updates
2.9 Barr Labs, Inc.
2.9.1 Barr Labs, Inc. Details
2.9.2 Barr Labs, Inc. Major Business
2.9.3 Barr Labs, Inc. Anti-Infective Vaccines Product and Services
2.9.4 Barr Labs, Inc. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Barr Labs, Inc. Recent Developments/Updates
2.10 Organon Teknika Co.
2.10.1 Organon Teknika Co. Details
2.10.2 Organon Teknika Co. Major Business
2.10.3 Organon Teknika Co. Anti-Infective Vaccines Product and Services
2.10.4 Organon Teknika Co. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Organon Teknika Co. Recent Developments/Updates
2.11 GlaxoSmithKline Biologicals
2.11.1 GlaxoSmithKline Biologicals Details
2.11.2 GlaxoSmithKline Biologicals Major Business
2.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product and Services
2.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 GlaxoSmithKline Biologicals Recent Developments/Updates
2.12 CSL Ltd.
2.12.1 CSL Ltd. Details
2.12.2 CSL Ltd. Major Business
2.12.3 CSL Ltd. Anti-Infective Vaccines Product and Services
2.12.4 CSL Ltd. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 CSL Ltd. Recent Developments/Updates
2.13 ID Biomedical Co.
2.13.1 ID Biomedical Co. Details
2.13.2 ID Biomedical Co. Major Business
2.13.3 ID Biomedical Co. Anti-Infective Vaccines Product and Services
2.13.4 ID Biomedical Co. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ID Biomedical Co. Recent Developments/Updates
2.14 Protein Sciences Co.
2.14.1 Protein Sciences Co. Details
2.14.2 Protein Sciences Co. Major Business
2.14.3 Protein Sciences Co. Anti-Infective Vaccines Product and Services
2.14.4 Protein Sciences Co. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Protein Sciences Co. Recent Developments/Updates
2.15 Wyeth Pharmaceuticals, Inc.
2.15.1 Wyeth Pharmaceuticals, Inc. Details
2.15.2 Wyeth Pharmaceuticals, Inc. Major Business
2.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product and Services
2.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
2.16 Berna Biotech
2.16.1 Berna Biotech Details
2.16.2 Berna Biotech Major Business
2.16.3 Berna Biotech Anti-Infective Vaccines Product and Services
2.16.4 Berna Biotech Anti-Infective Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Berna Biotech Recent Developments/Updates
3 Competitive Environment: Anti-Infective Vaccines by Manufacturer
3.1 Global Anti-Infective Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-Infective Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Anti-Infective Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-Infective Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-Infective Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-Infective Vaccines Manufacturer Market Share in 2022
3.5 Anti-Infective Vaccines Market: Overall Company Footprint Analysis
3.5.1 Anti-Infective Vaccines Market: Region Footprint
3.5.2 Anti-Infective Vaccines Market: Company Product Type Footprint
3.5.3 Anti-Infective Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-Infective Vaccines Market Size by Region
4.1.1 Global Anti-Infective Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-Infective Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Anti-Infective Vaccines Average Price by Region (2018-2029)
4.2 North America Anti-Infective Vaccines Consumption Value (2018-2029)
4.3 Europe Anti-Infective Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-Infective Vaccines Consumption Value (2018-2029)
4.5 South America Anti-Infective Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-Infective Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-Infective Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Anti-Infective Vaccines Consumption Value by Type (2018-2029)
5.3 Global Anti-Infective Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-Infective Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Anti-Infective Vaccines Consumption Value by Application (2018-2029)
6.3 Global Anti-Infective Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-Infective Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Anti-Infective Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Anti-Infective Vaccines Market Size by Country
7.3.1 North America Anti-Infective Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-Infective Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-Infective Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Anti-Infective Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Anti-Infective Vaccines Market Size by Country
8.3.1 Europe Anti-Infective Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-Infective Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-Infective Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-Infective Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-Infective Vaccines Market Size by Region
9.3.1 Asia-Pacific Anti-Infective Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-Infective Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-Infective Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Anti-Infective Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Anti-Infective Vaccines Market Size by Country
10.3.1 South America Anti-Infective Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-Infective Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-Infective Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-Infective Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-Infective Vaccines Market Size by Country
11.3.1 Middle East & Africa Anti-Infective Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-Infective Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-Infective Vaccines Market Drivers
12.2 Anti-Infective Vaccines Market Restraints
12.3 Anti-Infective Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-Infective Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-Infective Vaccines
13.3 Anti-Infective Vaccines Production Process
13.4 Anti-Infective Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-Infective Vaccines Typical Distributors
14.3 Anti-Infective Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Anti-Infective Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-Infective Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Emergent BioDefense Operations Lansing Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Emergent BioDefense Operations Lansing Inc. Major Business
Table 5. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product and Services
Table 6. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur Anti-Infective Vaccines Product and Services
Table 11. Sanofi Pasteur Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 14. Merck & Co. Major Business
Table 15. Merck & Co. Anti-Infective Vaccines Product and Services
Table 16. Merck & Co. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck & Co. Recent Developments/Updates
Table 18. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 19. MedImmune LLC Major Business
Table 20. MedImmune LLC Anti-Infective Vaccines Product and Services
Table 21. MedImmune LLC Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. MedImmune LLC Recent Developments/Updates
Table 23. Novartis Vaccines Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Vaccines Major Business
Table 25. Novartis Vaccines Anti-Infective Vaccines Product and Services
Table 26. Novartis Vaccines Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis Vaccines Recent Developments/Updates
Table 28. Diagnostics Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Diagnostics Ltd. Major Business
Table 30. Diagnostics Ltd. Anti-Infective Vaccines Product and Services
Table 31. Diagnostics Ltd. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Diagnostics Ltd. Recent Developments/Updates
Table 33. Intercell Biomedical Basic Information, Manufacturing Base and Competitors
Table 34. Intercell Biomedical Major Business
Table 35. Intercell Biomedical Anti-Infective Vaccines Product and Services
Table 36. Intercell Biomedical Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Intercell Biomedical Recent Developments/Updates
Table 38. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 39. MassBiologics Major Business
Table 40. MassBiologics Anti-Infective Vaccines Product and Services
Table 41. MassBiologics Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. MassBiologics Recent Developments/Updates
Table 43. Barr Labs, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Barr Labs, Inc. Major Business
Table 45. Barr Labs, Inc. Anti-Infective Vaccines Product and Services
Table 46. Barr Labs, Inc. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Barr Labs, Inc. Recent Developments/Updates
Table 48. Organon Teknika Co. Basic Information, Manufacturing Base and Competitors
Table 49. Organon Teknika Co. Major Business
Table 50. Organon Teknika Co. Anti-Infective Vaccines Product and Services
Table 51. Organon Teknika Co. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Organon Teknika Co. Recent Developments/Updates
Table 53. GlaxoSmithKline Biologicals Basic Information, Manufacturing Base and Competitors
Table 54. GlaxoSmithKline Biologicals Major Business
Table 55. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product and Services
Table 56. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 58. CSL Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. CSL Ltd. Major Business
Table 60. CSL Ltd. Anti-Infective Vaccines Product and Services
Table 61. CSL Ltd. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. CSL Ltd. Recent Developments/Updates
Table 63. ID Biomedical Co. Basic Information, Manufacturing Base and Competitors
Table 64. ID Biomedical Co. Major Business
Table 65. ID Biomedical Co. Anti-Infective Vaccines Product and Services
Table 66. ID Biomedical Co. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. ID Biomedical Co. Recent Developments/Updates
Table 68. Protein Sciences Co. Basic Information, Manufacturing Base and Competitors
Table 69. Protein Sciences Co. Major Business
Table 70. Protein Sciences Co. Anti-Infective Vaccines Product and Services
Table 71. Protein Sciences Co. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Protein Sciences Co. Recent Developments/Updates
Table 73. Wyeth Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Wyeth Pharmaceuticals, Inc. Major Business
Table 75. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product and Services
Table 76. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
Table 78. Berna Biotech Basic Information, Manufacturing Base and Competitors
Table 79. Berna Biotech Major Business
Table 80. Berna Biotech Anti-Infective Vaccines Product and Services
Table 81. Berna Biotech Anti-Infective Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Berna Biotech Recent Developments/Updates
Table 83. Global Anti-Infective Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Anti-Infective Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Anti-Infective Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Anti-Infective Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Anti-Infective Vaccines Production Site of Key Manufacturer
Table 88. Anti-Infective Vaccines Market: Company Product Type Footprint
Table 89. Anti-Infective Vaccines Market: Company Product Application Footprint
Table 90. Anti-Infective Vaccines New Market Entrants and Barriers to Market Entry
Table 91. Anti-Infective Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Anti-Infective Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Anti-Infective Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Anti-Infective Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Anti-Infective Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Anti-Infective Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Anti-Infective Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Anti-Infective Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Anti-Infective Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Anti-Infective Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Anti-Infective Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Anti-Infective Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Anti-Infective Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Anti-Infective Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Anti-Infective Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Anti-Infective Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Anti-Infective Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Anti-Infective Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Anti-Infective Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Anti-Infective Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Anti-Infective Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Anti-Infective Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Anti-Infective Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Anti-Infective Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Anti-Infective Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Anti-Infective Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Anti-Infective Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Anti-Infective Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Anti-Infective Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Anti-Infective Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Anti-Infective Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Anti-Infective Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Anti-Infective Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Anti-Infective Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Anti-Infective Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Anti-Infective Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Anti-Infective Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Anti-Infective Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Anti-Infective Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Anti-Infective Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Anti-Infective Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Anti-Infective Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Anti-Infective Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Anti-Infective Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Anti-Infective Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Anti-Infective Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Anti-Infective Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Anti-Infective Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Anti-Infective Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Anti-Infective Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Anti-Infective Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Anti-Infective Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Anti-Infective Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Anti-Infective Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Anti-Infective Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Anti-Infective Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Anti-Infective Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Anti-Infective Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Anti-Infective Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Anti-Infective Vaccines Raw Material
Table 151. Key Manufacturers of Anti-Infective Vaccines Raw Materials
Table 152. Anti-Infective Vaccines Typical Distributors
Table 153. Anti-Infective Vaccines Typical Customers
List of Figures
Figure 1. Anti-Infective Vaccines Picture
Figure 2. Global Anti-Infective Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-Infective Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Inactivated Vaccines Examples
Figure 5. Conjugate Vaccines Examples
Figure 6. Live/attenuated Vaccines Examples
Figure 7. Global Anti-Infective Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Anti-Infective Vaccines Consumption Value Market Share by Application in 2022
Figure 9. Bacterial Diseases Examples
Figure 10. Viral Diseases Examples
Figure 11. Global Anti-Infective Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Anti-Infective Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Anti-Infective Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Anti-Infective Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Anti-Infective Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Anti-Infective Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Anti-Infective Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Anti-Infective Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Anti-Infective Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Anti-Infective Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Anti-Infective Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Anti-Infective Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Anti-Infective Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Anti-Infective Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Anti-Infective Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Anti-Infective Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Anti-Infective Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Anti-Infective Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Anti-Infective Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Anti-Infective Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Anti-Infective Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Anti-Infective Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Anti-Infective Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Anti-Infective Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Anti-Infective Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Eu
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs